Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash Provided by (Used in) Operating Activities
Net earnings	$ 5,716	$ 5,259
Adjustments to reconcile net earnings to operating cash flows:
Depreciation and amortization	168	155
Deferred income tax provision (benefit)	215	(223)
Earnings from equity investment in AB InBev	(759)	(332)
Dividends from AB InBev	477	434
Loss (gain) on AB InBev/SABMiller business combination	33	(445)
Asset impairment and exit costs, net of cash paid	(24)	(30)
Cash effects of changes:
Receivables	(45)	4
Inventories	147	67
Accounts payable	(79)	(154)
Income taxes	308	341
Accrued liabilities and other current assets	(319)	(525)
Accrued settlement charges	757	(318)
Pension plan contributions	(19)	(18)
Pension provisions and postretirement, net	(19)	(70)
Other	9	(1)
Net cash provided by operating activities	6,566	4,144
Cash Provided by (Used in) Investing Activities
Capital expenditures	(132)	(151)
Proceeds from finance assets	0	133
Other	(5)	(184)
Net cash used in investing activities	(137)	(202)
Cash Used in Financing Activities
Repurchases of common stock	(1,317)	(2,359)
Dividends paid on common stock	(3,909)	(3,544)
Other	(25)	(47)
Net cash used in financing activities	(5,251)	(5,950)
Cash, cash equivalents and restricted cash:
Increase (decrease)	1,178	(2,008)
Balance at beginning of period	1,314	4,651
Balance at end of period	2,492	2,643
Cash, cash equivalents and restricted cash	$ 1,314	$ 4,651